Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.
Murray ML, Thompson M, Santosh PJ, Wong IC. Murray ML, et al. Among authors: santosh pj. Drug Saf. 2005;28(12):1151-7. doi: 10.2165/00002018-200528120-00009. Drug Saf. 2005. PMID: 16329717
Psychopharmacotherapy in children and adults with intellectual disability.
Santosh PJ, Baird G. Santosh PJ, et al. Lancet. 1999 Jul 17;354(9174):233-42. doi: 10.1016/S0140-6736(98)07059-7. Lancet. 1999. PMID: 10421318 Review.
Use of selective serotonin reuptake inhibitors in children and adolescents.
Wong IC, Besag FM, Santosh PJ, Murray ML. Wong IC, et al. Among authors: santosh pj. Drug Saf. 2004;27(13):991-1000. doi: 10.2165/00002018-200427130-00002. Drug Saf. 2004. PMID: 15471506 Review.
Does pervasive developmental disorder protect children and adolescents against drug and alcohol use?
Santosh PJ, Mijovic A. Santosh PJ, et al. Eur Child Adolesc Psychiatry. 2006 Jun;15(4):183-8. doi: 10.1007/s00787-005-0517-0. Epub 2006 Apr 7. Eur Child Adolesc Psychiatry. 2006. PMID: 16604379
Psychopharmacological treatment of behavioural problems in Sanfilippo syndrome.
Santosh P, Parker JR, Jones L. Santosh P, et al. BMJ Case Rep. 2009;2009:bcr07.2008.0480. doi: 10.1136/bcr.07.2008.0480. Epub 2009 Mar 17. BMJ Case Rep. 2009. PMID: 21686789 Free PMC article.
Development and psychometric properties of the parent version of the Profile of Neuropsychiatric Symptoms (PONS) in children and adolescents.
Santosh P, Gringras P, Baird G, Fiori F, Sala R. Santosh P, et al. BMC Pediatr. 2015 May 19;15:62. doi: 10.1186/s12887-015-0376-x. BMC Pediatr. 2015. PMID: 25986431 Free PMC article.
Pediatric Antipsychotic Use and Outcomes Monitoring.
Santosh PJ, Bell L, Fiori F, Singh J. Santosh PJ, et al. J Child Adolesc Psychopharmacol. 2017 Aug;27(6):546-554. doi: 10.1089/cap.2015.0247. Epub 2016 Sep 8. J Child Adolesc Psychopharmacol. 2017. PMID: 27607909 Review.
Architecture and functioning of child and adolescent mental health services: a 28-country survey in Europe.
Signorini G, Singh SP, Boricevic-Marsanic V, Dieleman G, Dodig-Ćurković K, Franic T, Gerritsen SE, Griffin J, Maras A, McNicholas F, O'Hara L, Purper-Ouakil D, Paul M, Santosh P, Schulze U, Street C, Tremmery S, Tuomainen H, Verhulst F, Warwick J, de Girolamo G; MILESTONE Consortium. Signorini G, et al. Lancet Psychiatry. 2017 Sep;4(9):715-724. doi: 10.1016/S2215-0366(17)30127-X. Epub 2017 Jun 6. Lancet Psychiatry. 2017. PMID: 28596067
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group.
Cortese S, Asherson P, Sonuga-Barke E, Banaschewski T, Brandeis D, Buitelaar J, Coghill D, Daley D, Danckaerts M, Dittmann RW, Doepfner M, Ferrin M, Hollis C, Holtmann M, Konofal E, Lecendreux M, Santosh P, Rothenberger A, Soutullo C, Steinhausen HC, Taylor E, Van der Oord S, Wong I, Zuddas A, Simonoff E; European ADHD Guidelines Group. Cortese S, et al. Lancet Child Adolesc Health. 2020 Jun;4(6):412-414. doi: 10.1016/S2352-4642(20)30110-3. Epub 2020 Apr 17. Lancet Child Adolesc Health. 2020. PMID: 32311314 Free PMC article. No abstract available.
12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.
Hoare P, Remschmidt H, Medori R, Ettrich C, Rothenberger A, Santosh P, Schmit M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE. Hoare P, et al. Eur Child Adolesc Psychiatry. 2005 Sep;14(6):305-9. doi: 10.1007/s00787-005-0486-3. Eur Child Adolesc Psychiatry. 2005. PMID: 16220214 Clinical Trial.
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback